[HTML][HTML] Cyclin A and cyclin D1 as significant prognostic markers in colorectal cancer patients

AA Bahnassy, ARN Zekri, S El-Houssini… - BMC …, 2004 - Springer
AA Bahnassy, ARN Zekri, S El-Houssini, AMR El-Shehaby, MR Mahmoud, S Abdallah…
BMC gastroenterology, 2004Springer
Background Colorectal cancer is a common cancer all over the world. Aberrations in the cell
cycle checkpoints have been shown to be of prognostic significance in colorectal cancer.
Methods The expression of cyclin D1, cyclin A, histone H3 and Ki-67 was examined in 60
colorectal cancer cases for co-regulation and impact on overall survival using
immunohistochemistry, southern blot and in situ hybridization techniques. Immunoreactivity
was evaluated semi quantitatively by determining the staining index of the studied proteins …
Background
Colorectal cancer is a common cancer all over the world. Aberrations in the cell cycle checkpoints have been shown to be of prognostic significance in colorectal cancer.
Methods
The expression of cyclin D1, cyclin A, histone H3 and Ki-67 was examined in 60 colorectal cancer cases for co-regulation and impact on overall survival using immunohistochemistry, southern blot and in situ hybridization techniques. Immunoreactivity was evaluated semi quantitatively by determining the staining index of the studied proteins.
Results
There was a significant correlation between cyclin D1 gene amplification and protein overexpression (concordance = 63.6%) and between Ki-67 and the other studied proteins. The staining index for Ki-67, cyclin A and D1 was higher in large, poorly differentiated tumors. The staining index of cyclin D1 was significantly higher in cases with deeply invasive tumors and nodal metastasis. Overexpression of cyclin A and D1 and amplification of cyclin D1 were associated with reduced overall survival. Multivariate analysis shows that cyclin D1 and A are two independent prognostic factors in colorectal cancer patients.
Conclusions
Loss of cell cycle checkpoints control is common in colorectal cancer. Cyclin A and D1 are superior independent indicators of poor prognosis in colorectal cancer patients. Therefore, they may help in predicting the clinical outcome of those patients on an individual basis and could be considered important therapeutic targets.
Springer